3 recruiting, 2 completed, 1 unknown. 6 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 6 | Recruiting 3, Completed 2, Unknown 1 |
Follow Communication Disorders: new trials by email Literature Review of Communication Disorders trials Research Report on Communication Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Aprepitant for the Treatment of CLIFAHDD Aprepitant Powder for Oral Suspension - CLIFAHDD, Congenital Contractures of the Limbs and Face, Hypotonia, and Developmental Delay | Early Phase 1 | Recruiting | The University of Texas Health Science Center at San Antonio | 5 | 2026-10-31 | 2026-10-05 |
| Propranolol in Primary Progressive Aphasia Propranolol, Magnetic Resonance Imaging (MRI), Placebo - Aphasia, Primary Progressive | Early Phase 1 | Recruiting | University of Missouri-Columbia | 30 | 2025-01-13 | 2026-07-17 |
| Educational Support Group Program for Bilingual and Spanish-speaking Carepartners and People With Progressive Aphasia Psychosocial educational, support group and implementation of strategies - Alzheimer Disease, Dementia | Early Phase 1 | Recruiting | University of Texas at Austin | 120 | 2024-05-21 | 2026-06-10 |
| Efficacy of START (Startle Rehabilitation Therapy) in the Treatment Stroke-induced Aphasia/Apraxia Startle Adjuvant Rehabilitation Therapy (START) - Stroke, Aphasia | Early Phase 1 | Unknown | Arizona State University | 54 | 2020-07-22 | 2022-02-22 |
| rTMS as a Treatment for PPA Active rTMS, SHAM rTMS - Logopenic Variant Primary Progressive Aphasia, Non-Fluent Primary Progressive Aphasia | Early Phase 1 | Completed | Massachusetts General Hospital | 12 | 2019-12-01 | 2022-04-07 |
| Breakpoint Analysis of de Novo Apparently Balanced Chromosomal Translocations Identification of breakpoints - Balanced Chromosomal Translocation | Early Phase 1 | Completed | University Hospital, Montpellier | 10 | 2011-10-01 | 2026-06-12 |
Aphasia (2) · Aphasia, Primary Progressive (2) · Learning Disabilities (2) · Alzheimer Disease (1) · Apraxias (1) · Ataxia (1) · Channelopathies (1) · Dementia (1) · Disease (1) · Facies (1) · Muscle Hypotonia (1) · Neurodevelopmental Disorders (1) · Primary Progressive Nonfluent Aphasia (1) · Stroke (1) · Translocation, Genetic (1)
Nervous System Diseases (6) · Neurobehavioral Manifestations (6) · Neurologic Manifestations (6) · Pathological Conditions, Signs and Symptoms (6) · Signs and Symptoms (6) · Mental Disorders (5) · Brain Diseases (4) · Central Nervous System Diseases (4) · Language Disorders (4) · Speech Disorders (4) · Neurocognitive Disorders (3) · Aphasia (2) · Dementia (2) · Neurodegenerative Diseases (2)
Aprepitant (1) · Magnetic Resonance Imaging (1) · Propranolol (1) · Self-Help Groups (1) · Suspensions (1)
Arizona State University (1) · Massachusetts General Hospital (1) · The University of Texas Health Science Center at San Antonio (1) · University Hospital, Montpellier (1) · University of Missouri-Columbia (1) · University of Texas at Austin (1)
United States (5) · France (1)
David Beversdorf, MD (1) · Jacques MD Puechberty, PHD (1) · Megan Iammarino, DPT (1)